CVRx (CVRX) Other Non Operating Income (2020 - 2026)
CVRx's (CVRX) quarterly Other Non Operating Income came in at $593000.0 in Q1 2026, down 47.2% year-on-year from $1.1 million in Q1 2025, and up 128.24% quarter-over-quarter from -$2.1 million in Q4 2025.
CVRx (CVRX) Other Non Operating Income (2020 - 2026) Analysis & Trends
CVRx's Other Non Operating Income history runs 7 years deep, the most recent figure standing at $593000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 47.2% year-over-year to $593000.0 in Q1 2026; TTM through Mar 2026 was $478000.0, a 49.84% decrease from a year earlier, with the FY2025 full-year figure at $1.0 million, up 15.33% from the prior year.
- Other Non Operating Income rose to $593000.0 in Q1 2026 per CVRX's latest filing, from -$2.1 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.1 million in Q4 2022 and bottomed at -$2.1 million in Q4 2025.
- The 5-year median for Other Non Operating Income is $917000.0 (2024), against an average of $452823.5.
- Across the five-year window, Other Non Operating Income soared 1963.16% in 2023 and plunged 281.99% in 2024, its largest moves.
- Year by year, Other Non Operating Income stood at $1.1 million in 2022, then retreated by 1.76% to $1.1 million in 2023, then plunged by 281.99% to -$2.0 million in 2024, then declined by 3.4% to -$2.1 million in 2025, then surged by 128.24% to $593000.0 in 2026.
- Per Business Quant, the three latest CVRX Other Non Operating Income figures stand at $593000.0 (Q1 2026), -$2.1 million (Q4 2025), and $875000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | CVRx | 128.88 Mn | 56.58 Mn | 12.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 593,000.00 |
| Dec 31, 2025 | -2.10 Mn |
| Sep 30, 2025 | 875,000.00 |
| Jun 30, 2025 | 1.11 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | -2.03 Mn |
| Sep 30, 2024 | 917,000.00 |
| Jun 30, 2024 | 944,000.00 |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 1.12 Mn |
| Sep 30, 2023 | 1.06 Mn |
| Jun 30, 2023 | 616,000.00 |
| Mar 31, 2023 | 1.06 Mn |
| Dec 31, 2022 | 1.14 Mn |
| Sep 30, 2022 | 328,000.00 |
| Jun 30, 2022 | -34,000.00 |
| Mar 31, 2022 | -57,000.00 |
| Dec 31, 2021 | -1.36 Mn |
| Sep 30, 2021 | 1.80 Mn |
| Jun 30, 2021 | -11.44 Mn |